Nore KG, Louet C, Bugge M, Gidon A, Jøntvedt Jørgensen M, Jenum S, Dyrhol-Riise AM, Tonby K, Flo TH(2023) The Cyclooxygenase 2 inhibitor etoricoxib as adjunctive therapy in tuberculosis impairs macrophage control of mycobacterial growth J Infect Dis(in press) DOI 10.1093/infdis/jiad390, PubMed 37721470
Murphy SL, Halvorsen B, Holter JC, Huse C, Tveita A, Trøseid M, Hoel H, Kildal AB, Holten AR, Lerum TV, Skjønsberg OH, Michelsen AE, Aaløkken TM, NOR-SOLIDARITY Consortium, The Norwegian SARS-CoV-2 study group investigators, Tonby K, Lind A, Dudman S, Granerud BK, Heggelund L, Bøe S, Dyrholt-Riise AM, Aukrust P, Barratt-Due A, Ueland T, Dahl TB(2023) Circulating markers of extracellular matrix remodelling in severe COVID-19 patients J Intern Med(in press) DOI 10.1111/joim.13725, PubMed 37718572
Gunst JD, Højen JF, Pahus MH, Rosás-Umbert M, Stiksrud B, McMahon JH, Denton PW, Nielsen H, Johansen IS, Benfield T, Leth S, Gerstoft J, Østergaard L, Schleimann MH, Olesen R, Støvring H, Vibholm L, Weis N, Dyrhol-Riise AM, Pedersen KBH, Lau JSY, Copertino DC, Linden N, Huynh TT, Ramos Vet al.(2023) Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial Nat Med(in press) DOI 10.1038/s41591-023-02547-6, PubMed 37696935